Page 8 - CUA 2020_Endourology
P. 8

2020 CUA Abstracts





        UP-1.9                                               UP-1.10
        Robotic-assisted laparoscopic technique for repair of iatrogenic   Urological use of nephrostomy tubes for ureteric obstruction
        ureteric injuries from gynecologic surgeries – the Edmonton   Nick Dean , Gillian Shiau , Shubhadip (Shubha) K. De , Tim Wollin 1
                                                                     1
                                                                               2
                                                                                                   1
        experience                                           1 Urology, University of Alberta, Edmonton, AB, Canada;  Interventional
                                                                                                     2
        Alexandra Bain , Blair A. St Martin , Michael G. Hobart 1  Radiology, University of Alberta, Edmonton, AB, Canada
                   1
                                1
        1 Urology, University of Alberta, Edmonton, AB, Canada  Introduction: We aimed to assess the use of nephrostomy tube drain-
        Introduction: The incidence of iatrogenic genitourinary injuries occur-  age with and without antegrade stenting over a six-year period. The pri-
        ring at the time of gynecologic surgery for benign disease is estimated   mary objective was to identify if there was a change in the volume of
        at 1%, with approximately 70% of injuries involving the bladder and   nephrostomy tubes placed over time and to describe the indication for
        30% involving the ureters.  Recently, centers performing high volumes of   placement for both benign and malignant causes of ureteric obstruction.
                          1
        robotic-assisted laparoscopic surgery have converted to using a robotic-  The secondary objective of our study was to better delineate the role of
        assisted approach to repair these injuries, but only a handful of series have   the urologist in the setting of patients with both benign and malignant
        been published on this novel approach. Edmonton has one of the high-  ureteric obstruction.
        est volumes of robotic-assisted laparoscopic surgery in Canada and has   Methods: We performed a retrospective analysis of percutaneous neph-
        been using a robotic approach for repair of these injuries. We performed   rostomy requisition data provided by the Interventional Radiology depart-
        a review of the indications, technique, and postoperative outcomes of   ment in Edmonton, Alberta from 2013–2019. Using patient identifiers,
        these repairs at our center.                         long-term outcome data was tracked from 2013 to present using the
        Methods: A case study of patients from January 2018 to September 2019   electronic medical record at the Kipnes Urology Center and compiled
        who underwent robotic assisted laparoscopic repair of iatrogenic ureteric   in our database.
        injuries from gynecologic surgery for benign disease were reviewed.  Results: From 2013 to present, a total of 1247 nephrostomy tubes were
        Results: Six patients were identified that had iatrogenic ureteric injuries   inserted in Edmonton. The incidence of nephrostomy tube insertion
        from gynecologic surgery that were repaired with a robotic-assisted lapa-  increased linearly from 156 in 2013 to 246 in 2018. The main indication
        roscopic approach. Five of six cases were a delayed repair with an average   for new nephrostomy tube placement was malignancy in 45% and stone
        of three months (94 days) between time of injury and time of repair. All   disease in 22% in 2018; 50% (18/36) of patients who had a nephrostomy
        injuries were in the distal ureter requiring ureteroneocystostomy. Followup   tube placed for non-prostate cancer malignant hydronephrosis were dead
        for all patients included a cystogram two weeks postoperatively, cystoscopy,   within one year and 35% (12/34) of patients receiving a nephrostomy
        stent removal 4–8 weeks postoperatively, and renal scan at 3–4 months.   tube for an obstructing ureteric stone had a previous failed cystoscopic
        All patients had complete resolution of ureteric obstruction by six months,   placement of a retrograde stent. For other services that initiated a nephros-
        with no evidence of leak, stricture, or persistent obstruction (Table 1).  tomy tube insertion, urology became involved in 95% of cases last year.
        Conclusions: Robotic-assisted laparoscopic repair of iatrogenic injuries   Conclusions: Our system’s use of nephrostomy tubes is increasing. Using
        post-gynecologic surgery is an effective technique, with all patients hav-  this database, we will attempt to discover predictors of failed retrograde
        ing successful resolution of obstruction. In the era of minimally invasive   stent placement by cystoscopy in the setting of obstructing ureteric stones,
        surgery and patient expectations, this technique offers patients an option   failed indwelling stents in the setting of malignant hydronephrosis, evaluate
        to resolve a surgical complication with potentially less morbidity than a   one- vs. two-stage nephrostomy tubes and antegrade stents, and shed light
        traditional open repair.                             on the optimal treatment strategy for treating causes of ureteric obstruction.
        Reference
        1.   Gellhaus PT, Bhandari A, Monn MF, et al. Robotic management of   UP-1.11
            genitourinary injuries from obstetric and gynecological operations:   Effect of 2012 and 2017 United States Preventive Services Task Force
            A multi-institutional report of outcomes. BJU Int 2015;115:430-6.   prostate-specific antigen screening guidelines on prostate cancer
            https://doi.org/10.1111/bju.12785
                                                             grade and age of diagnosis: A single-center, retrospective study
                                                                                                          1
                                                             Samantha McGirr , Luke Wang , Jinfeng Jiang , Bryant Van Leeuwen , Chad
                                                                         1
                                                                                  1
                                                                                           1
                                                             A. LaGrange , Shawna L. Boyle 1
                                                                      1
                                                             1 Department of Urology, University of Nebraska Medical Center, Omaha,
                                                             NE, United States
         UP-1.9. Table 1. Intraoperative and postoperative results of   Introduction: In 2017, the United States Preventive Services Task Force
         robotic-assisted laparoscopic repair of iatrogenic ureteric   (USPSTF) updated its prostate-specific antigen (PSA) testing guidelines,
         injuries from gynecological surgery                 issuing a grade “C” recommendation for men 55–69 years old, making
                                                                                                  1
                                                             whether to undergo routine testing a personal decision.  This changed from
                                           Number of patients
                                                             the USPSTF’s 2012 Grade “D” recommendation, which recommended
         Location of ureteric injury                         against routine testing. After the 2012 recommendation, a 3–10% decline
          Proximal                               0/6         in PSA screening was seen in all age groups. The effects of the 2012 and
                                                                                            2
          Mid                                    0/6         2017 guideline on age and cancer severity at initial diagnosis is unclear.
          Distal                                 6/6         Methods: This study analyzed all patients with biopsy-confirmed prostate
                                                             cancer at the University of Nebraska Medical Center from 2005–2019
         Operative technique used for repair     6/6         (n=647). Patients were split into those diagnosed prior to the 2012 recom-
          Ureteroneocystostomy
                                                             mendation (group 1; n=179), between the 2012 and 2017 recommenda-
         Postoperative followup                              tions (group 2; n=276), and after the 2017 recommendation (group 3;
         Cystogram 2 weeks                       6/6         n=192). Age of diagnosis and biopsy Gleason were obtained for each
         Cystoscopy and stent removal 4–6 weeks  6/6         group and compared against each other. A Bonferroni correction was
         Renal scan 3 months                     6/6         employed, with statistically significant p-value set at 0.017.
                                                             Results: Mean age at diagnosis was 61.7±6.6 years. Group 1’s mean age
         Resolution of obstruction                           (60.3±6.4) did not significantly differ from group 2 (61.6±6.6; p=0.046)
          Yes                                    6/6         but was less than group 3 (63.3±6.5; p<0.001). Group 2’s mean age was
          No                                     0/6         less than group 3 (p=0.007).
         Clavien Dindo complications >grade II   1/6         Conclusions: The USPSTF updates have been associated with significant
                                                             rise in age of cancer diagnosis and a decrease in the diagnosis of GGG1
         Average length of hospital stay post-repair  2 days
                                                             cancer, as expected. However, with each update, there is a significant
                                                             increase in the rates of both GGG4 and GGG5. Furthermore, GGG3 rates
        S46                                     CUAJ • June 2020 • Volume 14, Issue 6(Suppl2)
   3   4   5   6   7   8   9   10   11   12   13